Hims & Hers Health, Inc.(HIMS)Earnings, Financials & Key Ratios

HIMS•NYSE

$26.88

$6.94B mkt cap·52.7× P/E·Price updated May 6, 2026

SectorHealthcare IndustryMedical Equipment Sub-IndustryDigital Health and Care Delivery

AboutHims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.Show more

Revenue$2.35B+59.0%
EBITDA$176M+123.1%
Net Income$128M+1.8%
EPS (Diluted)0.51-3.8%
Gross Margin59.31%-25.3%
EBITDA Margin7.51%+40.3%
Operating Margin5.18%+23.6%
Net Margin5.47%-35.9%
ROE25.23%-17.9%
ROIC10.73%-39.3%
Debt/Equity2.07+8605.0%

Technical→

HIMS Key Insights

Hims & Hers Health, Inc. (HIMS) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓High quality earnings: Operating CF exceeds net income
✓Strong 5Y sales CAGR of 73.6%
✓Good 3Y average ROE of 16.3%
✓Efficient asset utilization: 1.1x turnover

✗Weaknesses

✗High debt to equity ratio of 2.1x
✗Trading more than 30% below 52-week high
✗Expensive at 12.8x book value

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

HIMS Price & Volume

Hims & Hers Health, Inc. (HIMS) stock price & volume — 10-year historical chart

Loading chart...

HIMS Growth Metrics

Hims & Hers Health, Inc. (HIMS) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-

5 Years73.63%

3 Years64.55%

TTM59%

Profit CAGR

10 Years-

5 Years-

3 Years-

TTM1.85%

EPS CAGR

10 Years-

5 Years-

3 Years-

TTM-4.32%

Return on Capital

10 Years-31.41%

5 Years-11.14%

3 Years5.62%

Last Year10.88%

HIMS Recent Earnings

Hims & Hers Health, Inc. (HIMS) EPS & revenue vs analyst estimates — last 4 quarters

Full history →

●Beat EPS 8/12 qtrs (67%)●Beat Revenue 6/12 qtrs (50%)

Q1 2026Latest

Feb 23, 2026

EPS

$0.07

Est $0.02

+250.0%

Revenue

$618M

Est $619M

-0.2%

Q4 2025

Nov 3, 2025

EPS

$0.06

Est $0.09

-33.3%

Revenue

$599M

Est $618M

-3.1%

Q3 2025

Aug 4, 2025

EPS

$0.17

Est $0.18

-5.6%

Revenue

$545M

Est $584M

-6.7%

Q2 2025

May 5, 2025

EPS

$0.20

Est $0.12

+65.4%

Revenue

$586M

Est $539M

+8.8%

Quarter	Date	EPS (Act vs Est)	Revenue (Act vs Est)
Q1 2026Latest	Feb 23, 2026	$0.07vs $0.02+250.0%	$618Mvs $619M-0.2%
Q4 2025	Nov 3, 2025	$0.06vs $0.09-33.3%	$599Mvs $618M-3.1%
Q3 2025	Aug 4, 2025	$0.17vs $0.18-5.6%	$545Mvs $584M-6.7%
Q2 2025	May 5, 2025	$0.20vs $0.12+65.4%	$586Mvs $539M+8.8%

Based on last 12 quarters of dataView full earnings history →

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	FCF Yield	Debt / Equity
TDOCTeladoc Health, Inc.Direct Competitor	1.2B	6.66	-5.84	-1.54%	-6.81%	-12.37%	23.76%	0.75
DOCSDoximity, Inc.Direct Competitor	5.19B	25.77	23.22	19.98%	37.54%	24.45%	5.14%	0.01
OPRXOptimizeRx CorporationDirect Competitor	123.59M	6.63	24.56	18.78%	4.69%	4.22%	15.1%	0.04
WELLWelltower Inc.Direct Competitor	150.14B	214.30	154.17	35.82%	12.31%	3.49%	1.9%	0.49
NVONovo Nordisk A/SProduct Competitor	151.36B	44.89	12.41	2.34%	33.14%	50.76%	5.88%	0.67
LLYEli Lilly and CompanyProduct Competitor	933.66B	988.19	43.06	44.7%	34.98%	101.17%	0.96%	1.60
AMWLAmerican Well CorporationProduct Competitor	106.78M	6.41	-1.08	-1.98%	-48.16%	-33.48%		0.02
TALKTalkspace, Inc.Product Competitor	871.07M	5.20	130	22%	3.4%	6.89%

Compare HIMS vs Peers

Hims & Hers Health, Inc. (HIMS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs TDOC

Most directly comparable listed peer for HIMS.

Scale Benchmark

vs LLY

Larger-name benchmark to compare HIMS against a more recognizable public peer.

Peer Set

Compare Top 5

vs TDOC, DOCS, OPRX, WELL

HIMS Income Statement

Hims & Hers Health, Inc. (HIMS) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25
Sales/Revenue	82.56M	148.76M	271.88M	526.92M	872M	1.48B	2.35B
Revenue Growth %	-	80.18%	82.77%	93.81%	65.49%	69.33%	59%
Cost of Goods Sold	37.95M	39.31M	67.38M	118.19M	157.05M	303.38M	955.21M
COGS % of Revenue	45.97%	26.42%	24.78%	22.43%	18.01%	20.55%	40.69%
Gross Profit	44.6M▲ 0%	109.45M▲ 145.4%	204.49M▲ 86.8%	408.72M▲ 99.9%	714.95M▲ 74.9%	1.17B▲ 64.1%	1.39B▲ 18.7%
Gross Margin %	54.03%	73.58%	75.22%	77.57%	81.99%	79.45%	59.31%
Gross Profit Growth %	-	145.38%	86.84%	99.87%	74.92%	64.09%	18.69%
Operating Expenses	119.02M	124.59M	319.54M	477.42M	744.4M	1.11B	1.27B
OpEx % of Revenue	144.16%	83.76%	117.53%	90.61%	85.37%	75.26%	54.13%
Selling, General & Admin	119.02M	113.36M	249.56M	370.78M	576.32M	846.61M	1.12B
SG&A % of Revenue	144.16%	76.2%	91.79%	70.37%	66.09%	57.34%	47.77%
Research & Development	0	11.24M	22.38M	29.24M	48.23M	78.82M	149.3M
R&D % of Revenue	-	7.55%	8.23%	5.55%	5.53%	5.34%	6.36%
Other Operating Expenses	0	0	47.59M	77.4M	119.86M	185.8M	0
Operating Income	-74.41M▲ 0%	-15.14M▲ 79.6%	-115.04M▼ 659.7%	-68.7M▲ 40.3%	-29.45M▲ 57.1%	61.9M▲ 310.2%	121.69M▲ 96.6%
Operating Margin %	-90.14%	-10.18%	-42.31%	-13.04%	-3.38%	4.19%	5.18%
Operating Income Growth %	-	79.65%	-659.65%	40.29%	57.13%	310.18%	96.58%
EBITDA	-74.15M	-14.09M	-110.97M	-61.22M	-19.94M	78.99M	176.19M
EBITDA Margin %	-89.82%	-9.47%	-40.81%	-11.62%	-2.29%	5.35%	7.51%
EBITDA Growth %	-	81%	-687.73%	44.83%	67.43%	496.18%	123.05%
D&A (Non-Cash Add-back)	260K	1.06M	4.08M	7.47M	9.52M	17.09M	54.5M
EBIT	-71.61M	-15.14M	-115.04M	-68.7M	-29.45M	61.9M	123.92M
Net Interest Income	-369K	-10K	0	0	0	0	0
Interest Income	0	0	0	0	0	0	0
Interest Expense	369K	10K	0	0	0	0	0
Other Income/Expense	2.44M	-2.84M	4.25M	2.99M	7.88M	9.81M	2.24M
Pretax Income	-71.97M▲ 0%	-17.99M▲ 75.0%	-110.8M▼ 516.0%	-65.71M▲ 40.7%	-21.57M▲ 67.2%	71.71M▲ 432.4%	123.92M▲ 72.8%
Pretax Margin %	-87.18%	-12.09%	-40.75%	-12.47%	-2.47%	4.86%	5.28%
Income Tax	90K	127K	-3.14M	-31K	1.98M	-54.33M	-4.44M
Effective Tax Rate %	-0.13%	-0.71%	2.83%	0.05%	-9.16%	-75.76%	-3.58%
Net Income	-72.06M▲ 0%	-18.11M▲ 74.9%	-107.66M▼ 494.3%	-65.68M▲ 39.0%	-23.55M▲ 64.1%	126.04M▲ 635.3%	128.37M▲ 1.8%
Net Margin %	-87.29%	-12.18%	-39.6%	-12.46%	-2.7%	8.54%	5.47%
Net Income Growth %	-	74.86%	-494.34%	38.99%	64.15%	635.28%	1.85%
Net Income (Continuing)	-72.06M	-18.11M	-107.66M	-65.68M	-23.55M	126.04M	128.37M
Discontinued Operations	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0
EPS (Diluted)	-2.07▲ 0%	-0.51▲ 75.4%	-0.58▼ 13.7%	-0.32▲ 44.8%	-0.11▲ 65.6%	0.53▲ 581.8%	0.51▼ 3.8%
EPS Growth %	-	75.36%	-13.73%	44.83%	65.63%	581.82%	-3.77%
EPS (Basic)	-2.07	-0.51	-0.58	-0.32	-0.11	0.58	0.57
Diluted Shares Outstanding	34.76M	35.35M	186.78M	204.52M	209.34M	236.81M	258.23M
Basic Shares Outstanding	34.76M	35.35M	186.78M	204.52M	209.34M	215.94M	224.96M
Dividend Payout Ratio	-	-	-	-	-	-	-

HIMS Balance Sheet

Hims & Hers Health, Inc. (HIMS) balance sheet — assets, liabilities & shareholders' equity

Line item	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25
Total Current Assets	69.61M	113.08M	269.9M	216.59M	265.05M	395.83M	767.64M
Cash & Short-Term Investments	60.37M	100.21M	247.27M	179.63M	220.98M	300.25M	577.49M
Cash Only	22.65M	27.34M	71.78M	46.77M	96.66M	220.58M	228.62M
Short-Term Investments	37.72M	72.86M	175.49M	132.85M	124.32M	79.67M	348.88M
Accounts Receivable	859K	750K	3.58M	3.23M	6.75M	6.08M	32.15M
Days Sales Outstanding	3.8	1.84	4.8	2.24	2.82	1.5	5
Inventory	4.22M	3.54M	13.56M	21.56M	22.46M	64.43M	80.13M
Days Inventory Outstanding	40.56	32.9	73.44	66.59	52.21	77.51	30.62
Other Current Assets	480K	5.89M	890K	1.78M	4.2M	8.9M	77.87M
Total Non-Current Assets	2.46M	5.61M	150.68M	149.75M	176.13M	311.71M	1.39B
Property, Plant & Equipment	0	0	5.11M	16.14M	45.73M	92.96M	448.98M
Fixed Asset Turnover	-	-	53.19x	32.66x	19.07x	15.88x	5.23x
Goodwill	0	0	110.88M	110.88M	110.88M	112.73M	278.32M
Intangible Assets	0	59K	25.89M	21.84M	18.57M	43.41M	196.12M
Long-Term Investments	0	204.53M	0	0	0	0	351.26M
Other Non-Current Assets	2.46M	-198.97M	8.8M	889K	947K	1M	29.68M
Total Assets	72.07M▲ 0%	118.7M▲ 64.7%	420.58M▲ 254.3%	366.34M▼ 12.9%	441.19M▲ 20.4%	707.54M▲ 60.4%	2.15B▲ 204.5%
Asset Turnover	1.15x	1.25x	0.65x	1.44x	1.98x	2.09x	1.09x
Asset Growth %	-	64.7%	254.34%	-12.9%	20.43%	60.37%	204.54%
Total Current Liabilities	20.62M	15.23M	79.22M	47.94M	88.47M	221.37M	404.43M
Accounts Payable	7.23M	8.07M	19.64M	32.36M	43.07M	91.18M	143.28M
Days Payables Outstanding	69.54	74.9	106.38	99.94	100.1	109.7	54.75
Short-Term Debt	1.51M	0	0	0	0	0	4.84M
Deferred Revenue (Current)	753K	1.27M	3.19M	1.47M	7.73M	75.28M	127.16M
Other Current Liabilities	9.1M	1.57M	0	0	0	0	119.51M
Current Ratio	3.38x	7.43x	3.41x	4.52x	3.00x	1.79x	1.90x
Quick Ratio	3.17x	7.19x	3.24x	4.07x	2.74x	1.50x	1.70x
Cash Conversion Cycle	-25.19	-40.16	-28.14	-31.12	-45.07	-30.68	-19.13
Total Non-Current Liabilities	186.74M	250.34M	6.75M	6.66M	8.69M	9.46M	1.21B
Long-Term Debt	0	0	0	0	0	0	1.12B
Capital Lease Obligations	0	0	4.12M	3.65M	8.67M	9.46M	143.17M
Deferred Tax Liabilities	0	0	0	0	0	0	28.86M
Other Non-Current Liabilities	186.74M	250.34M	2.63M	3.01M	22K	0	-78.42M
Total Liabilities	207.36M	265.57M	85.97M	54.6M	97.16M	230.82M	1.61B
Total Debt	1.51M	0	5.48M	5.31M	9.95M	11.35M	1.12B
Net Debt	-21.13M	-27.34M	-66.3M	-41.47M	-86.72M	-209.24M	891.97M
Debt / Equity	-	-	0.02x	0.02x	0.03x	0.02x	2.07x
Debt / EBITDA	-	-	-	-	-	0.14x	6.36x
Net Debt / EBITDA	-	-	-	-	-	-2.65x	5.06x
Interest Coverage	-201.66x	-1514.40x	-	-	-	-	-
Total Equity	-135.29M▲ 0%	-146.87M▼ 8.6%	334.62M▲ 327.8%	311.74M▼ 6.8%	344.03M▲ 10.4%	476.72M▲ 38.6%	540.93M▲ 13.5%
Equity Growth %	-	-8.56%	327.83%	-6.84%	10.36%	38.57%	13.47%
Book Value per Share	-3.89	-4.15	1.79	1.52	1.64	2.01	2.09
Total Shareholders' Equity	-135.29M	-146.87M	334.62M	311.74M	344.03M	476.72M	540.93M
Common Stock	4.5M	5K	20K	21K	21K	22K	23K
Retained Earnings	-153.18M	-171.29M	-278.95M	-344.63M	-368.18M	-242.14M	-113.77M
Treasury Stock	0	0	0	0	0	0	0
Accumulated OCI	2K	-11K	-137K	-277K	-124K	-324K	2.29M
Minority Interest	0	0	0	0	0	0	0

HIMS Cash Flow Statement

Hims & Hers Health, Inc. (HIMS) cash flow — operating, investing & free cash flow history

Line item	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25
Cash from Operations	-74.87M	-2.48M	-34.41M	-26.53M	73.48M	251.08M	300.01M
Operating CF Margin %	-90.68%	-1.67%	-12.66%	-5.04%	8.43%	17.01%	12.78%
Operating CF Growth %	-	96.69%	-1288.14%	22.9%	376.97%	241.69%	19.48%
Net Income	-72.06M	-18.11M	-107.66M	-65.68M	-23.55M	126.04M	128.37M
Depreciation & Amortization	260K	1.06M	4.08M	7.47M	9.52M	17.09M	54.5M
Stock-Based Compensation	8.03M	5.83M	67.21M	42.82M	66.08M	92.32M	135.24M
Deferred Taxes	0	0	-3.39M	-594K	-13K	-61.65M	-12.96M
Other Non-Cash Items	-1.24M	4.56M	1.89M	3.65M	626K	-1.34M	24.02M
Working Capital Changes	-9.85M	4.19M	3.46M	-14.2M	20.82M	78.62M	-29.16M
Change in Receivables	0	0	0	0	0	0	0
Change in Inventory	-522K	674K	-9.63M	-8M	-902K	-41.61M	-13.72M
Change in Payables	-6.08M	826K	9.85M	12.72M	7.32M	43.71M	30.3M
Cash from Investing	-39.3M	-39.7M	-156.27M	34.7M	-12.11M	-19.05M	-1.02B
Capital Expenditures	-308K	-1.74M	-832K	-2.71M	-17.22M	-41.66M	-226.04M
CapEx % of Revenue	0.37%	1.17%	0.31%	0.52%	1.97%	2.82%	9.63%
Acquisitions	0	0	-46.47M	-459K	0	-15.4M	-145.23M
Investments	-	-	-	-	-	-	-
Other Investing	-1.48M	-2.5M	-4.17M	-4.53M	-9.27M	-11.1M	-16.55M
Cash from Financing	95.32M	47.74M	235.04M	-33.13M	-11.47M	-107.84M	729.62M
Debt Issued (Net)	-6.92M	-1.51M	1.19M	0	0	0	918.78M
Equity Issued (Net)	1000K	1000K	1000K	0	-1000K	-1000K	-1000K
Dividends Paid	0	0	0	0	0	0	0
Share Repurchases	0	0	-22.03M	0	-2M	-83.04M	-89.96M
Other Financing	-333K	-2.64M	-16.81M	-33.13M	-9.48M	-24.81M	-116.67M
Net Change in Cash	-18.85M▲ 0%	5.55M▲ 129.5%	44.29M▲ 697.6%	-25.01M▼ 156.5%	49.89M▲ 299.5%	123.92M▲ 148.4%	8.03M▼ 93.5%
Free Cash Flow	-76.65M▲ 0%	-6.71M▲ 91.2%	-39.42M▼ 487.3%	-33.78M▲ 14.3%	46.99M▲ 239.1%	198.33M▲ 322.1%	73.96M▼ 62.7%
FCF Margin %	-92.85%	-4.51%	-14.5%	-6.41%	5.39%	13.43%	3.15%
FCF Growth %	-	91.24%	-487.29%	14.31%	239.12%	322.07%	-62.71%
FCF per Share	-2.21	-0.19	-0.21	-0.17	0.22	0.84	0.29
FCF Conversion (FCF/Net Income)	1.04x	0.14x	0.32x	0.40x	-3.12x	1.99x	2.34x
Interest Paid	361K	10K	0	0	0	0	0
Taxes Paid	139K	221K	338K	636K	1.11M	7.92M	0

HIMS Key Ratios

Hims & Hers Health, Inc. (HIMS) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2019	2020	2021	2022	2023	2024	2025
Return on Equity (ROE)	-	-	-114.69%	-20.32%	-7.18%	30.71%	25.23%
Return on Invested Capital (ROIC)	-	-	-183.38%	-19.13%	-8.37%	17.69%	10.73%
Gross Margin	54.03%	73.58%	75.22%	77.57%	81.99%	79.45%	59.31%
Net Margin	-87.29%	-12.18%	-39.6%	-12.46%	-2.7%	8.54%	5.47%
Debt / Equity	-	-	0.02x	0.02x	0.03x	0.02x	2.07x
Interest Coverage	-201.66x	-1514.40x	-	-	-	-	-
FCF Conversion	1.04x	0.14x	0.32x	0.40x	-3.12x	1.99x	2.34x
Revenue Growth	-	80.18%	82.77%	93.81%	65.49%	69.33%	59%

HIMS SEC Filings & Documents

Hims & Hers Health, Inc. (HIMS) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

Mar 11, 2026·SEC

Material company update

Feb 23, 2026·SEC

Material company update

Feb 19, 2026·SEC

10-K Annual Reports

FY 2026

Feb 23, 2026·SEC

10-Q Quarterly Reports

FY 2025

Nov 3, 2025·SEC

FY 2025

Aug 4, 2025·SEC

FY 2025

May 5, 2025·SEC

HIMS Frequently Asked Questions

Hims & Hers Health, Inc. (HIMS) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Hims & Hers Health, Inc. (HIMS) reported $2.35B in revenue for fiscal year 2025. This represents a 2744% increase from $82.6M in 2019.

Hims & Hers Health, Inc. (HIMS) grew revenue by 59.0% over the past year. This is strong growth.

Yes, Hims & Hers Health, Inc. (HIMS) is profitable, generating $128.4M in net income for fiscal year 2025 (5.5% net margin).

Dividend & Returns

Hims & Hers Health, Inc. (HIMS) has a return on equity (ROE) of 25.2%. This is excellent, indicating efficient use of shareholder capital.

Hims & Hers Health, Inc. (HIMS) generated $72.9M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More HIMS

Hims & Hers Health, Inc. (HIMS) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

Hims & Hers Health, Inc.(HIMS)Earnings, Financials & Key Ratios

HIMS Key Insights

✓Strengths

✗Weaknesses

HIMS Price & Volume

HIMS Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

HIMS Recent Earnings

HIMS Peer Comparison

Compare HIMS vs Peers

vs TDOC

vs LLY

Compare Top 5

HIMS Income Statement

HIMS Balance Sheet

HIMS Cash Flow Statement

HIMS Key Ratios

HIMS SEC Filings & Documents

8-K Announcements

10-K Annual Reports

10-Q Quarterly Reports

HIMS Frequently Asked Questions

Explore More HIMS

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation